Why Pfizer's Q2 Update Was Even Better Than You Might Think
Pfizer (NYSE: PFE) checked off all the boxes with its second-quarter results. The big drugmaker beat Wall Street revenue and earnings estimates. It also significantly increased full-year revenue and earnings guidance.
Investors cheered those results, with the pharma stock rising more than 3% on Wednesday. While that's a solid gain, it could have easily been even greater. Here's why Pfizer's Q2 update was even better than you might think.
Image source: Getty Images.
Source Fool.com
